ADCT logo

ADCT
Adc Therapeutics SA

1,258
Mkt Cap
$431.18M
Volume
648,500.00
52W High
$4.98
52W Low
$2.25
PE Ratio
-3.21
ADCT Fundamentals
Price
$3.39
Prev Close
$3.40
Open
$3.41
50D MA
$3.79
Beta
1.55
Avg. Volume
933,511.33
EPS (Annual)
-$1.12
P/B
-1.99
Rev/Employee
$421,538.86
$626.76
Loading...
Loading...

About

ADC Therapeutics SA is a clinical-stage biotechnology company, which engages in the research and development and commercialization of targeted antibody drug conjugates for patients with hematological malignancies and solid tumors. Its clinical-stage product candidates include loncastuximab tesirine, camidanlumab tesirine, and ADCT-602. The company was founded by Christopher Martin on June 6, 2011 and is headquartered in Epalinges, Switzerland.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
193

Frequently Asked Questions

What is Market Cap of Adc Therapeutics SA?
What is the 52-week high for Adc Therapeutics SA?
What is the 52-week low for Adc Therapeutics SA?
What is Adc Therapeutics SA stock price today?
What was Adc Therapeutics SA stock price yesterday?
What is the PE ratio of Adc Therapeutics SA?
What is the Price-to-Book ratio of Adc Therapeutics SA?
What is the 50-day moving average of Adc Therapeutics SA?
How many employees does Adc Therapeutics SA have?

Compact View

Mini-Chart
Sentiment
Not available
Message Volume
Not available